Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial.
Kahn SR, Shapiro S, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, Tagalakis V, Houweling AH, Ducruet T, Holcroft C, Johri M, Solymoss S, Miron MJ, Yeo E, Smith R, Schulman S, Kassis J, Kearon C, Chagnon I, Wong T, Demers C, Hanmiah R, Kaatz S, Selby R, Rathbun S, Desmarais S, Opatrny L, Ortel TL, Ginsberg JS; SOX trial investigators. Kahn SR, et al. Among authors: kassis j. Lancet. 2014 Mar 8;383(9920):880-8. doi: 10.1016/S0140-6736(13)61902-9. Epub 2013 Dec 6. Lancet. 2014. PMID: 24315521 Clinical Trial.
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M; Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators. Kearon C, et al. Among authors: kassis j. N Engl J Med. 2003 Aug 14;349(7):631-9. doi: 10.1056/NEJMoa035422. N Engl J Med. 2003. PMID: 12917299 Free article. Clinical Trial.
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor.
Kearon C, Ginsberg JS, Anderson DR, Kovacs MJ, Wells P, Julian JA, Mackinnon B, Demers C, Douketis J, Turpie AG, Van Nguyen P, Green D, Kassis J, Kahn SR, Solymoss S, Desjardins L, Geerts W, Johnston M, Weitz JI, Hirsh J, Gent M; SOFAST Investigators. Kearon C, et al. Among authors: kassis j. J Thromb Haemost. 2004 May;2(5):743-9. doi: 10.1046/j.1538-7836.2004.00698.x. J Thromb Haemost. 2004. PMID: 15099280 Free article. Clinical Trial.
Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis.
Kahn SR, Kearon C, Julian JA, Mackinnon B, Kovacs MJ, Wells P, Crowther MA, Anderson DR, Van Nguyen P, Demers C, Solymoss S, Kassis J, Geerts W, Rodger M, Hambleton J, Ginsberg JS; Extended Low-intensity Anticoagulation for Thrombo-embolism (ELATE) Investigators. Kahn SR, et al. Among authors: kassis j. J Thromb Haemost. 2005 Apr;3(4):718-23. doi: 10.1111/j.1538-7836.2005.01216.x. Epub 2005 Feb 23. J Thromb Haemost. 2005. PMID: 15733061 Free article. Clinical Trial.
Influence of warfarin on symptoms of fatigue: findings of a randomized trial.
Kovacs MJ, Kearon C, Julian JA, Douketis JD, Demers C, Wells PS, Turpie AG, Anderson DR, Kahn SR, Nguyen PV, Green D, Kassis J, Geerts W, Mackinnon B, Ginsberg JS. Kovacs MJ, et al. Among authors: kassis j. Ann Pharmacother. 2005 May;39(5):840-2. doi: 10.1345/aph.1E531. Epub 2005 Mar 15. Ann Pharmacother. 2005. PMID: 15769830 Clinical Trial.
The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-beta2-glycoprotein I antibodies.
Neville C, Rauch J, Kassis J, Solymoss S, Joseph L, Belisle P, Subang R, Chang ER, Fortin PR. Neville C, et al. Among authors: kassis j. Rheumatology (Oxford). 2006 Sep;45(9):1116-20. doi: 10.1093/rheumatology/kel050. Epub 2006 Mar 1. Rheumatology (Oxford). 2006. PMID: 16510527 Free PMC article.
VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis.
Kahn SR, Lamping DL, Ducruet T, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Johri M, Shrier I; VETO Study investigators. Kahn SR, et al. Among authors: kassis j. J Clin Epidemiol. 2006 Oct;59(10):1049-56. doi: 10.1016/j.jclinepi.2005.10.016. Epub 2006 Jun 23. J Clin Epidemiol. 2006. PMID: 16980144
175 results